Kangmei Pharmaceutical Co., Ltd.

Kangmei Pharmaceutical Co., Ltd. faced a notable decline in stock value, continuing a downward trend over the past week and month. The company has significantly underperformed compared to the broader market, with financial metrics indicating serious challenges, including a drastic decline in net profit and a low return on equity.

Kangmei Pharmaceutical Co., Ltd. saw a notable decline in its stock today, contrasting with the broader market's performance. The company has faced ongoing challenges, including stagnant net sales growth and significant drops in profit. Its long-term metrics indicate persistent underperformance in the competitive pharmaceuticals sector.